Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Pathologist
  • Explore Pathology

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Molecular Pathology
    • Infectious Disease
    • Digital Pathology

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Oncology
    • Histology
    • Cytology
    • Hematology
    • Endocrinology
    • Neurology
    • Microbiology & Immunology
    • Forensics
    • Pathologists' Assistants
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways
    • Workforce Trends

    Educational Resources

    • Guidelines & Recommendations
    • App Notes

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Profiles & Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

The Pathologist / Webinars / 2022 / Development of a predictive spatial signature in human tumors using Multiplexed Ion Beam Imaging
Diagnostics Microscopy and imaging Oncology Microbiology and Immunology

Development of a predictive spatial signature in human tumors using Multiplexed Ion Beam Imaging (MIBI)

Understanding the role of distinct cellular phenotypes in tissue function, development, and pathogenesis requires tools that can rapidly and consistently quantify the expression of multiple proteins while preserving spatial information.

02/24/2022 10:00am PST

Share

Available On-Demand

February 24th, 2022, at 10:00am PST

Understanding the role of distinct cellular phenotypes in tissue function, development, and pathogenesis requires tools that can rapidly and consistently quantify the expression of multiple proteins while preserving spatial information. To meet this need, we deployed Multiplexed Ion Beam Imaging (MIBI) to visualize up to 40 metal labeled antibodies at subcellular resolution.

Published recently in Cell, we used MIBI to examine ductal carcinoma in situ (DCIS)—a pre-invasive lesion thought to be a precursor to invasive breast cancer (IBC) revealing coordinated TME transitions delineated based on the location and function of myoepithelium, fibroblasts, and immune cells. This Breast PreCancer Atlas study offers new insight into drivers of IBC relapse and emphasizes the importance of the TME in regulating these processes.

Learning Objectives:

  • Understand the role of single-cell function with tissue structure context when researching the tumor microenvironment (TME) and other tissue disease states

  • Review the requirements for high-multiplex imaging when developing and implementing actionable spatial signatures to predict disease progression or patient response

  • Learn how multiplexed ion beam imaging was deployed to visualize 37 labeled antibodies at subcellular resolution in ductal carcinoma in situ (DCIS) revealing coordinated TME transitions to invasive breast cancer (IBC).

Newsletters

Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

More Webinars

Diagnostics Infectious Disease Omics Biochemistry and molecular biology

March 23, 2023

Using Single-Cell Sequencing to Investigate Murine COVID-19 Mortality

Subspecialties Oncology

December 1, 2022

Understanding the immune landscape of non-muscle invasive bladder cancer (NMIBC) and its influence on BCG immunotherapy

Diagnostics Omics

December 2, 2022

Unlocking Precision Oncology with Genomics - ESMO Roundtable

False

Advertisement

Recommended

False

False

The Pathologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.